Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLR1075 in Healthy Volunteers and Cirrhotic Patients with Hypoalbuminemia
NCT07851688Phase 1Not yet recruiting
- Sponsor
- Gan & Lee Pharmaceuticals
- Start
- Oct 2026
- Primary completion
- Dec 2028
- Countries
- 1
01
Overview
Phase 1, randomised trial of GLR1075 in hypoalbuminemia and ascites (3 arms), sponsored by Gan & Lee Pharmaceuticals. Primary endpoint: Adverse Events. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
GLR1075
03
Conditions
hypoalbuminemiaascites
Beyond the preview
Go deeper on NCT07851688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07851688.